Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
The British Journal of Psychiatry : the Journal of Mental Science|July 27, 2000
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depressionP Bech, P Cialdella, M C Haugh, et al.
BMC Psychiatry|January 31, 2003
Reliability, validity and psychometric properties of the Greek translation of the Major Depression InventoryK N Fountoulakis, A Iacovides, S Kleanthous, et al.
BMC Psychiatry|July 17, 2001
Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) ScaleK Fountoulakis, A Iacovides, S Kleanthous, et al.
Acta Psychiatrica Scandinavica|January 1, 1991
The Panic-Associated Symptom Scale: measuring the severity of panic disorderN Argyle, J Deltito, P Allerup, et al.
Clinical Pharmacology and Therapeutics|March 1, 1976
Plasma levels and antidepressive effect of imipramineL F Gram, N Reisby, I Ibsen, et al.
Psychotherapy and Psychosomatics|January 1, 1987
Integration of DSM-III and ICD-8 to be used in a consultation-liaison psychiatric service. Preliminary experiencesD L Poulsen, F Zierau, L Eplov, et al.
International Psychogeriatrics|September 15, 2006
Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residentsS Awata, P Bech, Y Koizumi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1983
The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliabilityP Bech, A Gjerris, J Andersen, et al.
Journal of Affective Disorders|May 1, 1983
The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disordersA Gjerris, P Bech, S Bøjholm, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neurolepticsP Bech, J C Peuskens, S R Marder, et al.
Pageof 21